US stock · Healthcare sector · Diagnostics & Research
Company Logo

Syneos Health, Inc.

SYNHNASDAQ

48.02

USD
-0.11
(-0.23%)
Market Closed
18.68P/E
9Forward P/E
0.93P/E to S&P500
4.929BMarket CAP
- -Div Yield
Scale: |
View:
Currency: USD, in millions
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
Income Statement
Revenue
656
869
995
1,179
1,399
1,611
2,672
4,390
4,676
4,416
5,213
COGS
499
679
775
884
1,027
1,207
2,051
3,434
3,646
- -
3,994
Gross Profit
157
190
220
295
372
404
621
956
1,030
4,416
1,218
Gross Profit Ratio
23.96%
21.88%
22.12%
25.00%
26.61%
25.07%
23.23%
21.77%
22.03%
100.00%
23.37%
Operating Expenses
159
188
176
200
213
232
463
680
689
4,123
806
R&D Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Selling, G&A Exp.
- -
- -
- -
- -
157
172
283
406
446
442
571
General and Admin. Exp.
- -
- -
- -
- -
157
172
283
406
446
442
- -
Selling and Marketing Exp.
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Expenses
159
188
176
200
56
59
180
274
242
3,680
236
COGS and Expenses
658
867
951
1,084
1,240
1,438
2,514
4,114
4,335
4,123
4,801
Interest Income
0
0
0
0
0
0
1
4
8
0
0
Interest Expense
66
62
61
53
16
12
64
131
130
(91)
79
Depreciation and Amortization
64
79
58
55
56
59
180
274
242
222
236
EBITDA
36
46
89
79
203
205
132
462
474
335
630
EBITDA ratio
5.43%
5.32%
8.90%
6.73%
14.48%
12.75%
4.93%
10.52%
10.14%
7.58%
12.09%
Operating Income
(40)
(38)
31
64
152
155
(29)
160
238
293
389
Operating Income ratio
(6.13)%
(4.32)%
3.16%
5.40%
10.89%
9.65%
(1.08)%
3.65%
5.08%
6.64%
7.47%
Total Other Income Exp.(Gains)
(54)
(57)
(62)
(92)
(21)
(21)
(83)
(103)
(136)
(89)
(74)
Income Before Tax
(94)
(95)
(31)
(28)
131
134
(112)
57
102
204
315
Income Before Tax ratio
(14.35)%
(10.92)%
(3.08)%
(2.39)%
9.36%
8.33%
(4.19)%
1.30%
2.18%
4.61%
6.05%
Income Tax Expense (Gain)
(35)
(36)
11
(5)
14
21
27
33
(30)
11
80
Net Income
(60)
(59)
(42)
(23)
117
113
(138)
24
131
193
235
Net Income Ratio
(9.08)%
(6.81)%
(4.17)%
(1.99)%
8.37%
6.99%
(5.18)%
0.55%
2.81%
4.37%
4.50%
EPS
(1.23)
(1.15)
(0.09)
(0.51)
2.02
2.08
(1.85)
0.23
1.27
1.85
2.25
EPS Diluted
(1.23)
(1.15)
(0.09)
(0.51)
1.95
2.03
(1.85)
0.23
1.25
1.83
2.23
Weighted Avg. Shares Outs.
52
52
60
53
58
54
75
103
104
104
104
Weighted Avg. Shares Outs. Dil.
52
52
60
53
60
56
75
105
105
105
105
Balance Sheet
Cash and Cash Equivalents
- -
81
97
126
85
102
321
154
164
272
106
Short-Term Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash & Short-Term Investments
- -
81
97
126
85
102
321
154
164
272
106
Net Receivables
- -
227
229
248
298
385
1,016
1,257
1,304
1,345
1,525
Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Current Assets
- -
46
50
52
39
35
85
81
95
121
135
Total Current Assets
- -
354
376
427
422
523
1,422
1,492
1,562
1,738
1,766
PP&E
- -
42
41
44
45
58
180
183
422
216
432
Goodwill
- -
565
563
557
553
553
4,293
4,333
4,350
4,776
4,956
Intangible Assets
- -
271
231
190
152
114
1,286
1,134
973
934
854
Goodwill and Intangible Assets
- -
836
794
747
705
667
5,579
5,467
5,323
5,710
5,810
Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Tax Assets
- -
5
4
16
12
15
20
9
37
- -
35
Other Non-Current Assets
- -
21
18
12
27
26
84
103
109
- -
193
Total Non-Current Assets
- -
903
857
818
789
766
5,864
5,763
5,892
5,926
6,471
Other Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Assets
- -
1,258
1,233
1,245
1,211
1,289
7,286
7,255
7,454
7,664
8,237
Accounts Payable
- -
17
10
17
22
24
59
99
137
114
108
Short-Term Debt
- -
6
7
5
30
12
41
64
114
60
64
Tax Payable
- -
6
5
11
4
1
17
31
17
29
26
Deferred Revenue
- -
200
207
247
311
278
559
777
697
35
868
Other Current Liabilities
- -
87
94
112
111
154
500
564
569
1,369
614
Total Current Liabilities
- -
310
318
380
475
467
1,160
1,503
1,516
1,577
1,654
Long-Term Debt
- -
586
587
415
472
486
2,946
2,737
2,550
2,902
3,016
Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Deferred Tax Liabilities
- -
22
29
30
28
8
38
25
11
- -
78
Other Non-Current Liabilities
- -
23
22
27
19
26
120
133
346
68
77
Total Non-Current Liabilities
- -
631
639
473
519
520
3,104
2,896
2,908
2,970
3,170
Other Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
6,214
- -
Capital Lease Obligations
- -
5
3
0
- -
- -
37
41
311
313
304
Total Liabilities
- -
941
957
853
994
987
4,263
4,399
4,424
4,821
4,825
Preferred Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Common Stock
- -
1
1
1
1
1
1
1
1
1
1
Retained Earnings
- -
(147)
(189)
(217)
(301)
(230)
(370)
(459)
(341)
- -
(13)
Other Compreh. Income(Loss)
- -
(10)
(10)
(26)
(42)
(42)
(22)
(88)
(72)
(41)
(50)
Other Total Stockhold. Equity
- -
472
474
635
560
573
3,414
3,403
3,441
3,282
3,474
Total Stockholders Equity
- -
317
276
392
217
301
3,023
2,856
3,030
3,242
3,413
Total Liab.&Stockhold. Equity
- -
1,258
1,233
1,245
1,211
1,289
7,286
7,255
7,454
8,063
8,237
Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
(399)
- -
Total Liabilities & Equity
- -
1,258
1,233
1,245
1,211
1,289
7,286
7,255
7,454
7,664
8,237
Cash Flow Statement
Net Income
(60)
(59)
(42)
(23)
117
113
(138)
24
131
193
235
Depreciation and Amortization
64
79
58
55
56
59
180
274
242
222
236
Deferred Income Tax
(37)
(45)
4
(15)
4
(22)
14
0
(40)
(4)
47
Stock Based Compensation
1
1
2
3
5
14
60
34
55
58
65
Change in Working Capital
5
59
6
45
8
(79)
47
(4)
(93)
(42)
(137)
Accounts Receivable
- -
- -
- -
- -
- -
- -
- -
(98)
- -
16
(109)
Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Accounts Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
25
Other Working Capital
18
24
9
44
54
18
32
(64)
(121)
(39)
(162)
Other Non-Cash Items
7
8
8
66
15
25
36
(25)
23
(3)
5
Cash Provided by Operating Activities
(19)
43
37
131
205
109
198
303
318
425
450
CAPEX
(5)
(10)
(18)
(26)
(21)
(31)
(44)
(55)
(64)
(50)
(57)
Acquisitions Net
(365)
(3)
- -
(2)
- -
- -
(1,679)
(91)
(18)
(454)
(285)
Purchases of Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Sales/Maturities of Investments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Other Investing Activities
- -
- -
- -
- -
- -
- -
(0)
- -
- -
- -
1
Cash Used for Investing Activities
(370)
(13)
(18)
(28)
(21)
(31)
(1,723)
(145)
(82)
(504)
(340)
Debt Repayment
(329)
(13)
(7)
(503)
(490)
(105)
(866)
(424)
(893)
(10)
(823)
Common Stock Issued
162
0
- -
156
- -
- -
- -
- -
- -
- -
- -
Common Stock Repurchased
(3)
(3)
(1)
(3)
(286)
(65)
- -
(75)
(57)
(70)
(118)
Dividends Paid
(5)
(1)
(1)
(0)
- -
- -
- -
- -
- -
- -
- -
Other Financing Activities
596
(3)
2
283
565
116
2,600
180
734
258
663
Cash Used/Provided by Financing Activities
422
(19)
(7)
(68)
(211)
(53)
1,734
(319)
(215)
178
(278)
Effect of Forex Changes on Cash
(4)
(1)
3
(6)
(14)
(7)
9
(5)
(14)
9
2
Net Change In Cash
30
10
16
29
(41)
17
219
(166)
8
108
(166)
Cash at the End of Period
71
81
97
126
85
102
321
156
164
272
106
Cash at the Beginning of Period
41
71
81
97
126
85
102
322
156
164
272
Free Cash Flow
(23)
33
20
106
184
78
154
249
255
375
393
Forex Rate
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -